Tarsus PharmaceuticalsI Valuation
| TARS Stock | USD 33.71 1.42 4.40% |
At this time, the company appears to be undervalued. Tarsus PharmaceuticalsInc has a current Real Value of $39.13 per share. The regular price of the company is $33.71. Our model measures the value of Tarsus PharmaceuticalsInc from inspecting the company fundamentals such as Return On Equity of -0.7, shares owned by insiders of 4.26 %, and Current Valuation of 909.22 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting Tarsus PharmaceuticalsI's valuation include:
Price Book 6.9008 | Enterprise Value 909.2 M | Enterprise Value Ebitda (8.82) | Price Sales 77.7428 | Enterprise Value Revenue 66.6106 |
Undervalued
Today
Please note that Tarsus PharmaceuticalsI's price fluctuation is very steady at this time. Calculation of the real value of Tarsus PharmaceuticalsInc is based on 3 months time horizon. Increasing Tarsus PharmaceuticalsI's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Tarsus PharmaceuticalsInc is useful when determining the fair value of the Tarsus stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Tarsus PharmaceuticalsI. Since Tarsus PharmaceuticalsI is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tarsus Stock. However, Tarsus PharmaceuticalsI's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 33.71 | Real 39.13 | Target 46.0 | Hype 31.72 |
The real value of Tarsus Stock, also known as its intrinsic value, is the underlying worth of Tarsus PharmaceuticalsInc Company, which is reflected in its stock price. It is based on Tarsus PharmaceuticalsI's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Tarsus PharmaceuticalsI's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tarsus PharmaceuticalsI's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tarsus PharmaceuticalsInc helps investors to forecast how Tarsus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tarsus PharmaceuticalsI more accurately as focusing exclusively on Tarsus PharmaceuticalsI's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Tarsus PharmaceuticalsI's intrinsic value based on its ongoing forecasts of Tarsus PharmaceuticalsI's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Tarsus PharmaceuticalsI's closest peers. When choosing an evaluation method for Tarsus PharmaceuticalsInc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Tarsus PharmaceuticalsI Investments |
|
Tarsus Valuation Trend
Knowing Tarsus PharmaceuticalsI's actual value is paramount for traders to make sound investment determinations. Tarsus PharmaceuticalsI's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Tarsus PharmaceuticalsI's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Tarsus PharmaceuticalsI's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Tarsus Market Cap
Tarsus PharmaceuticalsInc is rated third in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 8.02 Billion. Tarsus PharmaceuticalsI retains roughly 1.21 Billion in market capitalization claiming about 15% of equities under Health Care industry.Tarsus PharmaceuticalsI Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Tarsus PharmaceuticalsI's current stock value. Our valuation model uses many indicators to compare Tarsus PharmaceuticalsI value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tarsus PharmaceuticalsI competition to find correlations between indicators driving Tarsus PharmaceuticalsI's intrinsic value. More Info.Tarsus PharmaceuticalsInc is currently regarded as top stock in price to book category among related companies. It is currently regarded as top stock in price to sales category among related companies fabricating about 11.27 of Price To Sales per Price To Book. At this time, Tarsus PharmaceuticalsI's Price To Sales Ratio is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Tarsus PharmaceuticalsI by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tarsus PharmaceuticalsI's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tarsus PharmaceuticalsI's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Tarsus PharmaceuticalsI's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Tarsus PharmaceuticalsI and how it compares across the competition.
About Tarsus PharmaceuticalsI Valuation
The stock valuation mechanism determines the current worth of Tarsus PharmaceuticalsInc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Tarsus PharmaceuticalsInc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Tarsus PharmaceuticalsInc based exclusively on its fundamental and basic technical indicators. By analyzing Tarsus PharmaceuticalsI's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Tarsus PharmaceuticalsI's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tarsus PharmaceuticalsI. We calculate exposure to Tarsus PharmaceuticalsI's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Tarsus PharmaceuticalsI's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 15.9 M | 21 M | |
| Pretax Profit Margin | (7.79) | (7.40) | |
| Operating Profit Margin | (8.21) | (7.80) | |
| Net Loss | (7.79) | (7.40) | |
| Gross Profit Margin | 0.91 | 1.05 |
8 Steps to conduct Tarsus PharmaceuticalsI's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Tarsus PharmaceuticalsI's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Tarsus PharmaceuticalsI's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Tarsus PharmaceuticalsI's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Tarsus PharmaceuticalsI's revenue streams: Identify Tarsus PharmaceuticalsI's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Tarsus PharmaceuticalsI's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Tarsus PharmaceuticalsI's growth potential: Evaluate Tarsus PharmaceuticalsI's management, business model, and growth potential.
- Determine Tarsus PharmaceuticalsI's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Tarsus PharmaceuticalsI's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Tarsus PharmaceuticalsI Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Tarsus PharmaceuticalsI does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 29.4 M |
Tarsus PharmaceuticalsI Current Valuation Indicators
Valuation refers to the process of determining the present value of Tarsus PharmaceuticalsInc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Tarsus we look at many different elements of the entity such as Tarsus's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Tarsus PharmaceuticalsI's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Tarsus PharmaceuticalsI's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tarsus PharmaceuticalsI, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tarsus PharmaceuticalsI's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tarsus PharmaceuticalsI's worth.When determining whether Tarsus PharmaceuticalsInc is a strong investment it is important to analyze Tarsus PharmaceuticalsI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tarsus PharmaceuticalsI's future performance. For an informed investment choice regarding Tarsus Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tarsus PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Tarsus Stock analysis
When running Tarsus PharmaceuticalsI's price analysis, check to measure Tarsus PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus PharmaceuticalsI is operating at the current time. Most of Tarsus PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Tarsus PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Tarsus PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Tarsus PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tarsus PharmaceuticalsI. If investors know Tarsus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tarsus PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.62) | Revenue Per Share 0.594 | Quarterly Revenue Growth 0.308 | Return On Assets (0.36) | Return On Equity (0.70) |
The market value of Tarsus PharmaceuticalsInc is measured differently than its book value, which is the value of Tarsus that is recorded on the company's balance sheet. Investors also form their own opinion of Tarsus PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Tarsus PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tarsus PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Tarsus PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tarsus PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tarsus PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tarsus PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.